Pegenzileukin clinical trials

Isatuximab in Combination With Novel Agents in RRMM - Master Protocol

This study looks at new drug combinations with isatuximab and other treatments for a type of blood cancer called multiple myeloma. It aims to find better ways to treat patients whose cancer has come back or hasn't responded to previous treatments.